Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohort.
PLoS One. 2022 Nov 21;17(11):e0277606. doi: 10.1371/journal.pone.0277606. eCollection 2022.
PLoS One. 2022.
PMID: 36409695
Free PMC article.
Three-year efficacy of switching to dolutegravir plus lamivudine: A real-world study.
Palmier E, De Miguel R, Montejano R, Busca C, Micán R, Ramos L, Cadiñanos J, Serrano L, Bernardino JI, Pérez-Valero I, Valencia E, Arribas JR, Montes ML, González-García J, Martín-Carbonero L.
Palmier E, et al.
HIV Med. 2023 Sep;24(9):1013-1019. doi: 10.1111/hiv.13500. Epub 2023 May 16.
HIV Med. 2023.
PMID: 37194419
Item in Clipboard
Cite
Cite